TrimRx's Blog
Tirzepatide Results After 1 Year: Realistic Weight Loss Expectations
A full year of tirzepatide. Fifty-two weekly injections, multiple dose adjustments, behavioral resets, and a slow but real shift in baseline.
Tirzepatide Results After Month 1: Realistic Weight Loss Expectations
Four weeks of tirzepatide. You’\”re about to move from 2.5 mg to 5 mg, which is where the drug starts doing meaningful work.
Tirzepatide Pancreatitis: Risk Factors and Symptoms
Tirzepatide can cause acute pancreatitis, though rates in the SURMOUNT-1 trial (Jastreboff et al.
Tirzepatide How It Works: Mechanism of Action Explained
Introduction Tirzepatide is a dual agonist that activates two different gut hormone receptors at the same time: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like…
Can You Take Tirzepatide Long-Term?
Yes. Tirzepatide is FDA-approved for chronic use in both type 2 diabetes (Mounjaro) and obesity (Zepbound).
Tirzepatide Latest Research: New Indications, Trials & What’s Coming
The original tirzepatide trials targeted type 2 diabetes (SURPASS program) and obesity (SURMOUNT program).
When Will Tirzepatide Go Generic? Patent Timeline & Biosimilar Outlook
Tirzepatide (Mounjaro for diabetes, Zepbound for obesity) is Eli Lilly’s blockbuster dual GIP/GLP-1 receptor agonist. SURMOUNT-1 (Jastreboff et al.
Tirzepatide Who Should (and Shouldn’t) Take It: Eligibility & Contraindications
Introduction Tirzepatide has three FDA-approved indications as of 2026: type 2 diabetes (Mounjaro®), chronic weight management in adults with BMI 30+ or BMI 27+…
Tirzepatide Drug Interactions: What You Can and Can’t Take with It
Tirzepatide doesn’t have many serious drug interactions because it’s not metabolized through the CYP450 enzyme system the way most drugs are.
